Sana Biotechnology, Inc. (NASDAQ:SANA) Financings
Financings
| Raise | Date |
|---|---|
| Strategic investment of equity Announced: strategic investment Buyers: Mayo Clinic | Apr 13, 2026 |
| At-the-market programme of common stock Tranche closed: US$47.4M raised | Mar 3, 2026 |
| Public offering of common stock Closed: US$86.3M raised · US$3.35 a share · Morgan Stanley +3 Dealers: Morgan Stanley (co-lead), Goldman Sachs & Co. LLC (co-lead), BofA Securities (co-lead), TD Cowen (co-lead) | Aug 20, 2025 |